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ABSTRACT 
Structural variations (SVs) are an important and abundant source of variation in the 
human genome, encompassing a greater proportion of the genome as compared to 
single nucleotide polymorphisms (SNPs). This thesis investigates different aspects of 
SV analysis, focusing on copy number variations (CNVs) and regions of homozygosity 
(ROHs). It is divided into four main studies, each focusing on a different set of aims.  
In Study I, Identification of recurrent regions of copy-number variation across multiple 
individuals, we develop an algorithm and software to identify common CNV regions 
using individually segmented data. The identified common regions allow us to 
investigate population characteristics of CNVs, as well as to perform association 
studies.  
In Study II, Multi-platform segmentation for joint detection of copy number variants, 
we develop an algorithm to identify CNVs using intensity data from more than one 
platform. The algorithm is useful when researchers have data from multiple platforms 
on the same individual.  
In Study III, Regions of homozygosity in three Southeast-Asian populations, we identify 
ROHs in three Singapore populations, namely the Chinese, Malays and Indians. We 
characterize the regions and provide population summary statistics. We also investigate 
the relationship between the occurrence of ROHs and haplotype frequency, regional 
linkage disequilibrium (LD) and positive selection. The results show that frequency of 
occurrence of ROHs is positively associated with haplotype frequency and regional 
LD. The majority of regions detected for recent positive selection and regions with 
differential LD between populations overlap with the ROH loci. When we consider 
both the location of the ROHs and the allelic form of the ROHs, we are able to separate 
the populations by principal component analysis, demonstrating that ROHs contain 
information on population structure and the demographic history of a population. 
Last but not least, in Study IV, Statistical challenges associated with detecting copy 
number variants with next-generation sequencing technology, we describe and discuss 
areas of potential biases in CNV detection for each of four commonly used methods. In 
particular, we focus on issues pertaining to (1) mappability, (2) GC-content bias, (3) 
quality-control measures of reads, and (4) difficulties in identifying duplications. To 
gain insights to some of the issues discussed, we download real data from the 1000 
Genomes Project and analyze it in terms of depth of coverage (DOC). We show 
examples of how reads in repeated regions can affect CNV detection, demonstrate 
current GC correction algorithms, investigate sensitivity of DOC algorithm before and 
after quality-control of reads and discuss reasons for which duplications are harder to 
detect than deletions.  
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PREFACE 
I first started dabbling with genetic data during my 4
th
 year as a Statistics 
undergraduate in 2007. I was working on the Affymetrix 500K SNP array, one of the 
densest SNP microarrays at that time. Barely 5 years later, there are arrays with more 
than 5 million SNPs, not to mention Next-generation sequencing arrays that produce 
billions of reads in a single run. The technologies to study genetics have certainly 
evolved very rapidly, bringing with it new challenges in terms of statistical and 
bioinformatics analyses.   
When I first learnt of the term „CNV‟, the concept sounded simple to me: That we 
have regions of the genome that are deleted/duplicated, and that based on the intensity 
of our measurements, less intense means less of that particular region, and vice versa. 
“Not too complex!” I thought naively. As I continue to learn more, the multitude of 
problems/challenges that comes associated with the analysis of noise-rich CNV data 
is enormous. As put across aptly by John Ioannidis on genetic data from microarrays 
in general, “…this noise is so data-rich that minimum, subtle, and unconscious 
manipulation can generate spurious “significant” biological findings that withstand 
validations by the best scientists, in the best journals. Biomedical science would then 
be entrenched in some ultramodern middle ages, where tons of noise is accepted as 
“knowledge”. – The Lancet 365: 454-455.  
Nevertheless, I hope that with these four years of hard work, I have helped made a 
little more sense out of the massive amount of genetic data we have.   
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Chapter 1 – INTRODUCTION  
Genetic variation in the human genome can take many forms, including single-
nucleotide polymorphisms (SNPs), copy number variations (CNVs), indels, regions 
of homozygosity (ROHs), and other structural variants (SVs). In the last couple of 
years, genome-wide association studies (GWAS) have been widely used to correlate 
genetic differences to phenotypic variation, but they were largely focused on SNPs.  
CNVs and other SVs were less appreciated until two landmark studies in 2004 
identified widespread deletions and duplications in the human genome (Sebat et al., 
2004; Iafrate et al., 2004). By now, CNVs are widely recognized as a prevalent form 
of variation in the genome, encompassing a greater proportion of the genome as 
compared to SNPs. An estimated 1.2% of a single genome differs from the reference 
human genome when considering CNVs, as compared to 0.1% by SNPs (Pang et al., 
2010). Recent studies have found CNVs to be associated with complex diseases such 
as human immunodeficiency virus (HIV) infection, cancer, diabetes, mental disorders, 
obesity, Parkinson‟s disease and autoimmune diseases (Wain et al., 2009; The 
Wellcome Trust Case Control Consortium 2010). ROHs are also more abundant than 
previously thought (Gibson et al., 2006), and are associated with complex diseases 
such as schizophrenia and late-onset Alzheimer‟s disease (Lencz et al., 2007; Nalls et 
al., 2009). 
That, as compared to SNPs, the association of CNVs and ROHs with complex 
diseases is not as well-studied is in part due to greater complexity in identifying these 
multi-base, multi-allelic variants, and also greater complexity in performing 
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association studies with these variants. Early works on CNVs/ROHs have focused 
largely on identifying and characterizing regions in the genome which harbour them. 
This has been necessary in laying the foundation to improve our understanding of 
CNVs/ROHs for subsequent association analysis with human complex diseases.  
The most common technologies for CNVs identification in the last couple of years are 
high density SNP arrays and array comparative genomic hybridization (aCGH) arrays; 
the former (SNP arrays) are also commonly used for detection of ROHs. However, 
the data generated from these techniques are noisy, and identifying CNVs 
comprehensively with high resolution still remains a technical and statistical 
challenge. aCGH and SNP arrays are also limited by the resolution of the array to 
determine precise locations of CNV breakpoints, and are unable to locate copy-
neutral events such as inversions and translocations. 
Sanger sequencing, often seen as the gold standard for CNV detection, is able to 
detect CNVs with higher accuracy and resolution, to detect balanced rearrangements 
such as inversions and translocations, as well as to detect CNVs in regions where 
probe density of other platforms is low. However, the technique is not feasible for a 
large number of genomes due to time and budget constraints. Next-generation 
sequencing (NGS) attempts to combine the benefits of array technology and 
sequencing. The biggest advantage of NGS over traditional Sanger sequencing is the 
ability to sequence millions of reads in a single run at a comparatively inexpensive 
cost (Metzker, 2010). However, with billions of reads generated per individual, there 
is an increasing need for more bioinformatics support and computers with larger 
storage and higher computing powers, and for such support to keep pace with the 
12 
 
rapidly changing technologies. Already, there is a great demand for information 
technology infrastructure and bioinformatics team to analyse the massive amount of 
data, with speculations that the costs associated with down-handling, storing and 
analysis of the data could be more than the production of the data. 
There is still a need for the development of new statistical/bioinformatics methods 
and software for the systematic analysis of CNV/SV data. This is the focus of this 
thesis.  
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Chapter 2 – BACKGROUND  
In this chapter, I will introduce some concepts in CNV/ROH analysis, including 
definitions and introduction to existing technology, software and algorithms in 
detection of CNV/ROH. These will facilitate the understanding of subsequent 
chapters. 
2.1 Terminology and nomenclature 
Human genetic variations refer to differences in the deoxyribonucleic acid (DNA) 
sequences among different individuals; they can take many forms, including single-
nucleotide polymorphisms (SNPs), indels, copy number variations (CNVs), and other 
copy-neutral variations such as inversions, translocations and regions of 
homozygosity (ROHs). These genetic variations span a spectrum of sizes, ranging 
from 1 base-pair (bp) changes to whole chromosomal changes (e.g. aneuploidy). The 
occurrences of these genetic variations are attributed to different diverse mechanisms. 
For example, the predominant mechanisms for CNV formation include non-allelic 
homologous recombination and non-homologous end joining (Hastings et al., 2009; 
Conrad et al., 2010). ROHs are thought to be a result of autozygosity or uniparental 
isodisomy (Gibson et al., 2006).  
Table 2.1 summarizes the definitions of variants from single base changes to the sub-
microscopic level (larger variants are not discussed). Note that the definitions for the 
different classes of genetic variants based on size are often unclear at the edges of 
each class. For example, larger indels may sometimes be termed CNVs even when 
their sizes are less than 1 kb. 
14 
 
Types of variation Size Definition* Remarks 
SNVs, SNPs, 
single-nucleotide 
insertions-
deletions (indels) 
1 bp SNVs are variations of 
a single nucleotide (see 
Figure 1). When the 
variation is common 
(usually defined as 
having a frequency of 
more than 1%), we call 
it a SNP (Figure 2.1). 
Most SNPs are single  
nucleotide substitutions,  
although single nucleotide 
deletions/insertions may  
also fall under this category. 
Indels, 
microsatellites, 
minisatellites, 
inversions, di-,tri- 
tetranucleatide 
repeats, variable 
number of tandem 
repeats (VNTRs) 
2 to < 1000 
bp 
Indels are typically 
defined as insertions or 
deletions that are 
smaller than 1 kb and 
larger than 1 bp.  
The size cut off is rather 
arbitrary; Database of 
Genomic Variants (DGV) 
defines indels in the size 
range of 100 bp to 1 kb. 
CNVs, segmental 
duplications, 
inversions, 
translocations  
1000 bp to 
sub-
microscopic 
CNVs are additions or 
deletions in the number 
of copies of a segment 
of DNA (larger than 1 
kb in length) when 
compared to a 
reference genome 
(Figure 2.2). 
Some large indels larger 
than 500 bp may also be 
termed CNVs. Common 
CNV larger than 1% 
population frequency are 
termed copy number 
polymorphism (CNP). 
ROHs > 500 bp ROHs are continuous 
stretches of the genome 
(usually more than 500 
kb) without 
heterozygosity in the 
diploid state.  
 
Table 2.1: Definition of the different classes of genetic variations, partly adapted from 
Figure 1 of Scherer et al., 2007. *only selected types of variation are defined. 
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Figure 2.1: C-T single nucleotide variation.Source: 
http://en.wikipedia.org/wiki/File:Dna-SNP.svg 
 
 
Figure 2.2: Schematic and simplified diagram of a deletion and duplication (adapted 
from Ku et al., 2010). 
 
ROHs are sometimes termed loss of homozygosity (LOH), which includes 
hemizygous deletions (where there is only one copy of the region). Genotypes of 
SNPs within hemizygous deletions may be erroneously called as homozygous 
resulting in a region that may seem to be a ROH based on SNP genotypes alone. 
Figure 2.3 illustrates the differences in intensity patterns for ROH and one-copy 
deletion; while both ROH and one-copy deletion have similar B allele frequency 
(BAF) patterns, the Log R ratio (LRR) for ROH is around zero while it is below zero 
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for one-copy deletion. In this thesis, ROH always refer to the copy-neutral variant, 
where the region is in diploid state and all bases within the region are homozygous.   
 
Figure 2.3: (Left panel) ROH signature with LRR around zero and no clusters at BAF 
of 0.5. (Right panel) One copy deletion signature with decreased LRR and similar 
pattern of BAF as ROH. The x-axis is the genomic probe location and each point 
represents a probe in the SNP array. (Figure from Ku et al., 2011). 
2.2 CNV and ROH detection technologies 
In the last decade or so, the most commonly used technologies for CNV detection are 
whole-genome array comparative genome hybridization (aCGH) and high-density 
SNP arrays. ROHs are typically detected using high-density SNP arrays. 
CNVs/ROHs detected using these technologies are unfortunately limited by the 
density of the probes, as well as the location of the probes. For example, array 
platforms with more than 1 million probes have a lower detection limit of 10-25 kb in 
the size of CNV (McCarroll et al., 2008). Sanger sequencing provides better 
resolution and accuracy, but it is not cost/time-effective to use on a genome-wide 
scale for many individuals. The recent development of next generation sequencing 
(NGS) platforms that allow massive parallel sequencing have the potential to discover 
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smaller CNVs that were not previously discovered, detect balanced rearrangements 
such as inversions and translocations, as well as detect rare CNVs for which SNP 
arrays have no probes for. The biggest advantage over traditional Sanger sequencing 
is the ability to produce large amount of sequencing data in a single run.  
However, as compared to SNPs, detection of CNVs is more challenging because of its 
complexity as a multi-base, multi-allelic variant. As a result, different algorithms and 
methods often give vastly different estimates in the number and breakpoints of CNVs. 
Currently, in the Database of Genomic Variants (DGV), there are more than 130,000 
(merged) CNVs from 37 different studies, encompassing more than 52% of the 
genome; a likely gross overestimation of the true percentage of the genome 
encompassed by CNVs. This is because all the different studies use a heterogonous 
array of technologies, algorithms, filtering parameters, and samples.  
2.3 CNV and ROH detection algorithms 
Detection of CNVs from aCGH arrays is mostly based on locating change-points in 
intensity-ratio patterns that would partition each chromosome into several discrete 
segments. On the other hand, the hidden Markov model (HMM) is particularly 
popular for detection of CNVs from SNP arrays, where the hidden states provide a 
natural way of combining information from the total signal intensity (known as log R 
ratio, LRR) and the relative allele frequency (known as B allele frequency, BAF) 
values. Briefly, the HMM assumes several possible hidden states such as „deletion‟, 
„normal‟, „region of homozygosity‟ and „duplication‟ and analyse the most possible 
state-transition path, assuming that the copy numbers of nearby SNPs are dependent 
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(Wang et al., 2007). Illustrated in Figure 2.4, a „normal copy‟ has three BAF clusters 
and the LRR is centred around zero; a ROH has LRR centred around zero but only 
two clusters at both extremes of the BAF.  
The output from a CNV detection algorithm provides the following information: (1) 
Chromosome number (2) Start location (3) End location (4) Copy number. For 
example, this is a typical output from PennCNV:  
chr6:32565228-32593190 numsnp=30 "length=27,963" "state1,cn=0"  
It tells us that in Chromosome 6 of this individual, from the position 32565228 to 
position 32593190, there is a deletion where this individual has zero copies as 
compared to the reference panel. There are 30 probes in this region in the platform 
used, and the length of the region is 27,963 bases.   
 
Figure 2.4: Figure from Wang et al., 2007, illustrating the unique patterns in LRR and 
BAF of the different copy number states. A „normal copy‟ has three BAF clusters and 
the LRR is centred around zero; a ROH has LRR centred around zero but only two 
clusters at both extremes of the BAF.  
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2.4 Sequencing technologies 
2.4.1 First generation sequencing 
First generation sequencing is typically referred to as „Sanger sequencing‟, and is 
introduced by Frederick Sanger in 1977 (Sanger, 1977). It is the main form of 
sequencing technique used over the last 30 years until the arrival of next-generation 
sequencers in 2005. Sanger sequencing is able to sequence reads of length ~ 800- 
1000 bases (Hert et al., 2008; Schloss et al., 2008; Venter et al., 2001).  
However, Sanger sequencing is laborious and costly; its inability to process more than 
96 sequence reads at a time limits its application to large scale genome-wide 
sequencing efforts for many individuals (Mardis, 2008). For example, it took nearly 
ten years and three billion dollars to sequence the first human genome in the Human 
Genome Project (Schadt et al., 2010). 
2.4.2 Next-generation sequencing (NGS) 
Next-generation sequencing (NGS) or also known as high-throughput sequencing 
(HTS) is able to simultaneously sequence millions of DNA reads. This ability to 
produce large amount of sequencing data in a single run at a comparatively 
inexpensive cost is its biggest advantage over traditional Sanger sequencing (Metzker, 
2010). Currently available NGS sequencers in the market include the Roche 454 
Genome Sequencer FLX System, Illumina Genome Analyzer, Illumina HiSeq and 
Applied Biosystems‟ Supported Oligonucletide Ligation Detection System (SOLiD). 
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NGS has the potential to discover smaller CNVs that were not previously discovered, 
to detect balanced rearrangements such as inversions and translocations, as well as to 
detect CNVs in regions where probe density of other platforms, such as SNP arrays, 
is low. NGS technologies have facilitated and accelerated the process of identifying 
genetic variations through whole-genome re-sequencing projects, including the 1000 
Genomes Project.  
However, there are some technical features of NGS that result in several challenges. 
Firstly, due to an effect called „dephasing‟, there is an increase in noise and 
sequencing errors as the read length extends, thereby limiting the read lengths of NGS 
to ~35 – 400 bases (Schadt et al., 2010). The short read lengths in turn complicate 
alignment and assembly. Secondly, in order to generate a large number of DNA 
molecules, polymerase chain reaction (PCR) amplification is required. This 
amplification process biases the frequency in which different portions of the genome 
are sequenced (Schadt et al., 2010).   
2.4.3 CNV detection using NGS 
Broadly, there are four complementary methods for CNV detection using NGS data, 
namely (1) depth of coverage (DOC, also known as read-depth (RD) methods), (2) 
paired-end mapping (PEM), (3) split-read (SR) and (4) assembly-based (AS) methods 
(Alkan et al., 2011). Except for the latter, the other three classes of methods require 
first mapping the sequenced reads to a known reference genome. The different 
methods are usually complementary to one another as the underlying concepts excel 
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at detecting certain types of variants, and a large proportion of discovered variants 
remain unique to a particular approach (Alkan et al., 2011). 
Some algorithms use a combination of methods for more accurate detection of CNVs. 
For example, CNVer supplements DOC with PEM information in a unified 
framework (Medvedev et al., 2010). Genome STRiP combines information from 
DOC, PEM, SR as well as other features of sequence data at population level 
(Handsaker et al., 2011). Genome STRiP is one of the highest performing method 
used in the 1000 Genomes pilot Project, indicating that there is benefit in combining 
different approaches (Mills et al., 2011).    
Depth of coverage  
DOC methods typically count the number of reads that fall in each pre-specified 
window of a certain size (Abyzov et al., 2011; Yoon et al., 2009). The underlying 
concept of identifying CNVs using DOC is similar is that of using intensity data: a 
lower than expected DOC /intensity indicates deletion and a higher than expected 
DOC /intensity indicates duplication (Figure 2.5). The algorithm relies heavily on the 
assumption that the sequencing process is uniform, i.e., the number of reads mapping 
to a region is proportional to the number of copies. However, certain biases such as 
GC-content and mappability cause this assumption to be unrealistic; regions of the 
genome may be over or under-sampled regardless of the copy number of the region, 
often resulting in spurious signals. DOC algorithms usually detect large CNVs and 
are unable to detect copy neutral events such as inversions and translocations. Single-
end or paired-end data may be used for this analysis.  
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Figure 2.5: Schematic diagram illustrating the concept of depth of coverage method 
for CNV detection. If the sample has an additional copy relative to the reference 
genome, when the reads are mapped to the reference, we would observe an increase 
in depth of coverage in the region.  
Paired-end mapping 
PEM methods require the reads to be paired (Chen et al., 2009). The concept is that 
the fragments of DNA from which the reads are to be sequenced have a fragment 
length (or also known as insert size) of a certain distribution, and a longer than 
expected fragment length indicates a deletion in the studied genome compared to a 
reference while a shorter than expected fragment length indicates an insertion. Based 
on the patterns from which the paired reads are mapped to the reference, read pair 
analysis can also detect inversions and translocations. The size of CNVs detected 
using PEM is limited by the insert size and as a result, PEM often detects smaller 
CNVs. For example, PEM does not allow the discovery of insertions larger than the 
insert size (Dalca et al., 2010).   
Split-read 
SR methods uses paired reads as well. They focus on pairs of reads where one read is 
mapped to the reference while the other read failed to be aligned (Ye et al., 2009). 
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The idea is that where the location of the unmapped read may span the breakpoint of 
the CNV. SR analysis has the advantage of being able to pinpoint the location of the 
breakpoints.  
Assembly-based  
AS methods, on the other hand, do not align the reads to a known reference but 
construct the genome piece-by-piece, which is known as de novo sequencing. Some 
AS methods use the reference genome as a guide to resolve repeats. This is known as 
comparative assembly (Pop et al., 2004). AS methods can discover new non-
reference sequence insertions. AS methods works best for small genomes such as 
bacterial genomes and are less widely used in NGS sequencing of humans because 
the short reads from NGS makes assembly in repeat regions difficult (Ye et al., 2009). 
Even though assembly algorithms continue to improve, due to the short read lengths, 
de novo sequencing using NGS are still not capable of achieving similar quality as 
that using Sanger sequencing (Schadt et al., 2010).  
2.5 Repetitive DNA 
Repetitive DNA refers to sequences that are highly similar or identical to sequences 
in other parts of the genome. They are abundant in the human genome and covers 
almost 50% of the human genome (Treangen et al., 2012). Table 2.2 summarises 
repeat type, number, percentage of genome covered and approximate length of each 
repeat class. The repeat type is broadly characterized into tandem or interspersed 
repeats where the former refer to repeats that are adjacent to each other while the 
latter refers to repeats that are separated by hundreds, thousands or millions of bases.  
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In next generation sequencing, reads from repetitive regions may map equally well to 
several locations in the reference genome. Due to the ambiguity in the alignment step, 
these reads often cause problems in SNP and SV detection. Reads that can be mapped 
equally well to more than one location are termed multi-reads. 
Repeat class Repeat type Number % genome Length (bp) 
Minisatellite, 
microsatellite or satellite 
Tandem 426, 918 3% 2 -100 
SINEs Interspersed 1, 797, 575 15% 100 - 300 
DNA transposon Interspersed 463, 776 3% 200 - 2000 
LTR retrotransposon Interspersed 718, 125 9% 200 - 5000 
LINEs Interspersed 1, 506, 845 21% 500 - 8000 
rDNA Tandem 698 0.01% 2000 - 43000 
Segmental duplications 
and other classes 
Tandem or 
interspersed 
2, 270 0.20% 1000 - 100000 
Table 2.2: This table summarises for each repeat class, the repeat type (tandem or 
interspersed), number in the hg19 human genome, percentage of the hg19 human 
genome covered, and approximate lower and upper bounds for the lengths of the 
repeat. (Table adapted from Treangen et al., 2012). Short interspersed nuclear 
elements (SINEs), Long terminal repeat (LTR), Long interspersed nuclear elements 
(LINEs), ribosomal DNA (rDNA).  
2.6 Copy number variation region (CNVR)  
CNVR or also known as CNV loci or common CNV or recurrent CNV are CNVs that 
occur in the same/similar location across several individuals. Most CNV detection 
algorithms identify CNVs individual-by-individual, but common CNVs are known to 
exist among different individuals. However, the identification of the individual-
specific CNVs is not precise, especially in terms of the breakpoints. This poses a 
challenge when we want to summarize the population characteristics or perform 
association studies, because it is unclear if CNV1 from individual 1 describes 
biologically the same event as CNV2 from individual 2 if their breakpoints do not 
match exactly.  
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2.7 Hardy Weinberg Equilibrium of CNVR 
Suppose a bi-allelic SNP has allele frequencies p and q (where p+q = 1) for alleles a 
and b respectively, regardless of gender. Assuming random mating, in the next 
generation, the frequencies of the aa, ab and bb genotypes are p
2
, 2pq and q
2
 
respectively. The allele frequencies of a and b have not changed and remain p and q, 
such that in the following generation, the genotype frequencies will again be p
2
, 2pq 
and q
2
, and so forth. This is known as Hardy Weinberg Equilibrium (HWE); i.e., that 
the frequency of alleles and genotypes remain constant from generation to generation 
in a large population assuming random mating. The Pearson‟s chi-squared test is 
typically used to test for departure from these expected frequencies, indicating 
violation of HWE.  
Since it has been observed that the majority of common CNV regions are inherited 
(Locke et al., 2006), we expect, for a population of normal, healthy individuals, the 
integer copy numbers for the majority of CNVRs to be in HWE. This is supported by 
McCarroll et al., (2008)‟s study that found that 98% of common bi-allelic CNVRs do 
not violate HWE. McCarroll et al., (2008) also found that about 90% of common 
CNVs are bi-allelic.  
In principal, HWE applies to both bi-allelic CNVRs and multi-allelic CNVRs. Bi-
allelic CNVs are those with only two alleles, forming three possible copy numbers. 
For example, CNVs with copy numbers 0, 1, 2 or 2, 3, 4 are considered bi-allelic. 
Multi-allelic CNVs are those with more than two alleles, for example, with alleles „0‟, 
„1‟ and „2‟, the possible copy numbers are 0, 1, 2, 3 and 4. Testing HWE for bi-allelic 
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CNVs is straightforward and similar to the test for SNPs. However, for multi-allelic 
CNVRs, HWE test cannot be performed directly on the unphased copy-number 
because there is an issue with different combinations of alleles producing the same 
copy-number. For example, with alleles „0‟, „1‟ and „2‟, the copy number 2 can have 
genotype (1, 1) or (0, 2).   
2.8 GWAS of CNVs 
Genome-wide association studies (GWAS) using SNPs have been widely performed 
over the last couple of years, resulting in over 1400 published associations (at p ≤ 
5x10
-8
) for 237 traits (from the National Human Genome Research Institute: 
http://www.genome.gov/26525384). This is in part due to greater accuracy and 
completeness with which SNPs, as compared to CNVs, can be assayed.  
Earlier studies on CNV discovery have paved the way for subsequent association 
studies of CNVs. For example, the Wellcome Trust Case Control Consortium 
(WTCCC) performed a large scale GWAS study of CNVs in 16000 cases of eight 
common diseases using a customized aCGH that was designed based on previously 
identified CNVs (Wellcome Trust Case Control Consortium, 2010). The WTCCC 
study found several CNV loci to be associated with Crohn‟s disease, rheumatoid 
arthritis, type 1 diabetes and type 2 diabetes. However, these loci have been 
previously identified through SNP based GWAS, reflecting the observation that 
common CNVs are well tagged by SNPs.  
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2.9 Linkage disequilibrium 
The non-random association of alleles at two or more loci in the genome is known as 
linkage disequilibrium (LD), i.e. that the occurrences of some combinations of alleles 
at two or more loci are more or less frequent than expected based on their individual 
allele frequencies. For example, suppose allele A1 at SNP A and allele B1 at SNP B 
have frequencies p1 and q1 respectively. If the two SNPs are independent, then we 
expect to see the A1B1 haplotype at a frequency of p1q1; any departure from this 
expected frequency means that the two SNPs are in LD. Most commonly used 
statistics to quantify the extent of LD between two loci are the r
2 
and D’ statistics 
(Lewontin et al., 1960). Both statistics are based on the extent of departure of the 
observed haplotype frequency from the expected. Let x11 be the observed AB 
haplotype frequency. Then, D = x11 – p1q1. Now, let the other two alleles of SNP A 
and SNP B have frequencies p2 and q2 respectively.  
   
  
        
  and      
 
    
  where       {
   (         )         
   (         )         
 
Both measures have a minimum value of 0, which indicates independence between 
the two loci, and maximum value of 1, which indicates complete dependence between 
the two loci.  
2.10 Quantification of positive selection 
Positive selection is the phenomenon where certain variants rise to a frequency at a 
faster rate than would be expected, i.e., the favouring of variants that increase survival 
and reproduction. Under neutral evolution, new variants need a long time to reach 
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high frequency, resulting in common variants usually having short range LD because 
recombination would have occurred to disrupt the haplotypes (Sabeti et al., 2002).    
Hence, one „clue‟ or signature that provides evidence of positive selection is an 
unusually long and common haplotype which indicates an allele which rose to high 
frequency rapidly before recombination occurs (Bersaglieri et al., 2004). 
One statistic used to quantify positive selection is the integrated haplotype score (iHS) 
(Voight et al., 2006). Briefly, this score measures how unusual the haplotypes around 
a core SNP are, relative to the rest of the genome. The iHS first utilizes the extended 
haplotype homozygosity (EHH) statistic (Sabeti et al., 2002); the EHH measures the 
decay of haplotype identity as a function of distance. For each SNP, haplotype 
homozygosity starts at 1 and decays to zero with increasing distance. Alleles under 
selection tend to have high haplotype homozygosity that extends much further, 
resulting in a large area under the EHH curve. The iHS is a standardized measure of 
the integrated EHH. Clusters of SNPs with large positive or large negative iHS are 
evidence of position selection in the region.   
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Chapter 3 – AIMS 
Overall, the general aim of this thesis is to use and develop statistical and 
bioinformatics methods to improve detection and analyses of structural variants. The 
thesis is divided into four studies as follows:  
I. We develop a method and accompanying software to identify common CNV 
regions in multiple individuals. The identified common regions can be used 
for downstream analyses such as group comparisons in association studies. 
II. We develop a method and software to identify CNVs by using data from 
multiple platforms simultaneously. We also propose an objective criterion for 
discrete segmentation required for downstream analyses. For each identified 
segment, the software reports a p-value to indicate the likelihood of the 
segment being a true CNV. 
III. We investigate the population characteristics of ROHs in three Singapore 
populations (Chinese, Malays and Indians), and access the relationship 
between the occurrence of ROHs and haplotype frequency, regional LD and 
positive selection.  
IV. We highlight problems and issues encountered when analysing NGS data for 
CNVs, in particular, those pertaining to DOC methods. We use real data from 
the 1000 Genomes Project to highlight and investigate challenges associated 
with (1) GC-content, (2) quality score of reads, and (3) identifying CNVs in 
repeated regions.   
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Chapter 4 - PAPER SUMMARIES 
4.1 Study I: Identification of recurrent regions of copy-number variation across 
multiple individuals.  
4.1.1 Motivation 
Most algorithms for CNV-detection detect CNVs sample-by-sample with individual 
specific breakpoints. However, common CNV regions (CNVRs) are likely to occur at 
the same genomic locations across multiple individuals.  
4.1.2 Methods overview 
The main novelty of our algorithm is that we exploited the region specific confidence 
score statistic provided by commonly used segmentation programs, PennCNV and 
QuantiSNP. This statistic indicates how likely the detected CNV for a particular 
individual is true. By not incorporating the use of individual specific confidence 
scores, it means that all regions contribute equally to the statistic used to identify the 
common regions, but some regions are more likely to be true positives than others. 
Our method utilizes both the confidence score statistic, as well as the frequency of 
occurrence, to identify CNVRs. Intuitively, we have less confidence in a CNV that 
occurs in one individual than one that occurs in many individuals. However, a single 
occurrence of CNV might still be a true discovery if it is associated with a high 
confidence score, i.e., it is based on a strong signal. Since individual CNVs span 
different probes, the number of individual regions that overlap each probe varies. 
However, common CNV regions tend to occur at almost the same genomic locations 
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across multiple individuals. Hence, we expect the common regions to be identified by 
consecutive probes where a „significant‟ number of individuals have an overlapping 
CNV. Furthermore, we also expect the confidence score of the individual regions to 
be relatively high.  
Method 1: Cumulative Overlap Using Very Reliable Regions (COVER) 
To calculate the COVER statistic for a probe, we sum the number of high-confidence 
individual regions that overlap that probe. The common region is then defined as 
consecutive probes for which the COVER statistic is greater than or equal to a 
specified threshold, u. Users provide two parameters here: the confidence score 
threshold, c, to determine high-confidence regions and u, the threshold for the 
COVER statistic.  
Method 2: Cumulative Composite Confidence Scores (COMPOSITE) 
In COVER, we may miss regions that are detected with lower confidence scores but 
nonetheless detected consistently across a large number of individuals. For the 
COMPOSITE statistic, we sum all individual regions that overlap the probe, weighted 
by their confidence score.  
Method 3: Clustering of Individual CNV regions within a Common Region  
The CLUSTER method uses a clustering algorithm that further refines the regions 
identified by either method 1 or method 2. This method is motivated by the 
observation of a complex mixture of sub-regions within a CNVR identified by 
COVER/COMPOSITE (Figure 4.1). 
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Figure 4.1:  An example of a CNVR identified by COVER. We observe that despite 
being identified as a common region, the individual regions still portray a mixture 
phenomenon of several distinct sub-regions (from Teo et al., 2010).  
4.1.3 Results 
Comparison with sequenced regions 
To assess the performance of our methods, we use 112 HapMap samples and vary the 
threshold parameters in our methods. For each threshold, we calculate discordance 
rates with sequencing-based results (Kidd et al., 2008) and rates of departure from 
HWE. The discordance rates as well as the rates of departure from HWE decrease 
when we select CNVs with higher confidence scores, showing the importance of 
further processing of the CNVs (for COVER results, see Figure 4.2). Similar results 
were observed for COMPOSITE method (Figure not shown). Concordance rates 
improve after refinement with CLUSTER.  
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Figure 4.2: (a) Discordance rates for COVER method decreases as the confidence 
score thresholds increase. (b) Rates of departure from HWE decreases as the 
confidence score thresholds increase (from Teo et al., 2010).  
Comparison to other algorithms 
We compare our methods to two previously published methods, STAC (Diskin et al., 
2006) and GISTIC (Beroukhim et al., 2007). We find that our methods are better at 
identifying low-frequency but high-confidence CNV regions.  
Implementation 
The methods are implemented in an R package, cnvpack. The main input is a list of 
detected individual CNV regions with the following information: Sample name, 
chromosome number, detected integer copy number, start and end genomic locations 
and a confidence score. The package can be downloaded from 
http://www.meb.ki.se/~yudpaw.  
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4.2 Study II: Multi-platform segmentation for joint detection of copy number 
variants. 
4.2.1 Motivation 
At the time this research was carried out, SNP genotyping platforms from major 
commercial companies, such as Illumina and Affymetrix, were rapidly evolving, and 
it is not uncommon for research groups to have data from different platforms for the 
same individuals. For CNV detection, marker density is one important factor. 
Different platforms have different sets of marker panels and combining data from 
multiple platforms would undoubtedly give higher marker density. It has the potential 
to yield more precise and accurate detection of CNVs and its breakpoints. However, 
combining such data is not straightforward as different platforms show different 
degrees of attenuation of the true copy-number, noise characteristics and marker 
panels (Zhang et al., 2010). There is still a relative lack of formal procedures for 
combining information from different platforms for copy-number calling. Most 
studies with data from multiple platforms interrogating the same samples usually 
process the data independently for each platform, after which the identified segments 
are combined in an ad-hoc manner. This approach does not fully utilize information 
from the different platforms, and when the segmented results from the different 
platforms differ, it is difficult for researchers to come to a consensus in a statistically 
rigorous manner. 
In this study, we develop a new method for identifying CNVs by using data from 
multiple platforms simultaneously. As we are often interested in discrete segments of 
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CNVs for downstream analyses, we also develop an objective method to obtain 
discrete segments, and provide a p-value associated with each segment; the p-value 
would indicate how likely the segment is a CNV, and can be used to filter false 
positives. 
4.2.2 Methods overview  
The method, multi-platform smooth segmentation (MPSS) is an extension of Huang 
et al. (2007)‟s single-platform smoothseg algorithm which is based on the Cauchy 
random-effect model that allows jumps in the underlying copy-number patterns. 
MPSS uses normalized log2-intensity ratios from two or more platforms and estimates 
the underlying copy number pattern for an individual. For each individual, we denote 
{x1, …, xn} as the union of the probe locations from the different platforms, with x1 < 
x2 < … < xn. Denote {yx1j, …, yxnj} as the set of log2-intensity ratios from platform j. 
We write our model as  
      (   )       , 
where f is a random effects parameter that is common to all platforms, meaning that 
each platform is assumed to measure the same underlying copy-number pattern; as 
such, background normalization is recommended so that data from the different 
platforms become comparable. The error term exij is platform-specific to take into 
account different noise characteristics of the different platforms. The platform 
specific error structure was chosen to be t-distributed to incorporate a heavy tailed 
structure that can deal with outliers in the observations. The smoothness of f can be 
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expressed by assuming that the scaled second order differences 
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independent and identically distributed with some distribution. We specify *ia  
to 
follow the Cauchy distribution to allow for jumps in the segments. To estimate the 
random-effects parameter f, we derive an iterative weighted least squares algorithm 
by maximizing the likelihood of the Cauchy random-effects model.  
4.2.3 Results  
We compare MPSS against the single-platform smoothseg algorithm, an existing 
multiplatform method, called MPCBS (Zhang et al., 2010), and its associated single 
platform method, CBS (Olshen et al., 2004). We use nine HapMap samples, which 
were previously genotyped by both the Illumina 1M and Affymetrix 6.0 SNP arrays 
by our collaborators at the Genome Institute of Singapore, Agency for Science, 
Technology and Research. For the same samples, we have the integer copy-numbers 
from Conrad et al. (2010)‟s study, which we use as a reference list.    
When signals from the different platforms are consistent, we get increased power to 
detect the CNVs when we combine information from different platforms, especially 
in areas where a single platform has low density of probes (Figure 4.3a) or complete 
lack of probes (Figure 4.3b). To compare against other methods, we perform 
individual-specific comparisons with the reference list and report the number of 
overlapping bases as a proportion of the total length of CNVs identified by the 
method and as a proportion of the total length of CNVs in the reference list. In Figure 
4.4, we show that MPSS CNVs have greater amount of overlap with the reference, 
indicating better performance. 
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Implementation 
The algorithm is implemented in an R package MPSS that can be freely downloaded 
from http://www.meb.ki.se/∼yudpaw. The main inputs are vectors of genomic 
positions, chromosome numbers and log2-intensity ratios from each platform. 
 
Figure 4.3: Examples of segments detected by the multiplatform methods. (a) A 
deletion in Chromosome 8. Single platform smoothseg on Illumina platform was 
unable to identify the deletion due to lack of probes in the region. Single platform 
smoothseg on Affymetrix platform was unable to identify the deletion due to 
insufficient signal. (b) A deletion in Chromosome 16. Single platform smoothseg on 
Affymetrix platform was unable to identify the deletion due to complete lack of 
probes in the region. (c) A deletion in Chromosome 22 (from Teo et al., 2011).  
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Figure 4.4: The number of overlapping bases as a proportion of Conrad's CNVs and 
as a proportion of each method's CNVs; the different points for each method 
correspond to the different thresholds. A higher proportion of overlap indicates better 
performance (from Teo et al., 2011).  
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4.3 Study III: Regions of homozygosity (ROHs) in three Southeast Asian 
populations 
4.3.1 Motivation 
The genomes of outbred populations were first shown in 2006 to contain an 
abundance of long stretches > 500kb without heterozygosity (Gibson et al., 2006; Li 
et al., 2006). Since then, there have been several studies that investigate the 
population characteristics of ROHs in healthy individuals (McQuillan et al., 2008; 
Nothnagel et al., 2010; O‟Dushlaine et al., 2010), and also several studies that 
perform association analyses to identify ROHs that are associated with complex 
diseases (Yang et al., 2010; Lencz et al., 2007; Nalls et al., 2009). However, the 
majority of these studies are conducted on European populations, and there is a lack 
of knowledge of ROHs in Asian populations. Thus, the first aim is to characterize 
ROHs in the three main Singapore populations, namely the Chinese, Malays and 
Indians. 
Furthermore, it was observed that the location of ROHs is markedly non-random, 
where unrelated individuals may share similar region boundaries. Some loci are 
caused by a single common haplotypes, whereas others are a consequence of several 
common haplotypes that could be markedly disparate (Curtis et al., 2008). The 
second aim of this study is to investigate the relationship between the occurrence of 
ROHs and haplotype frequency, linkage disequilibrium (LD) and positive selection. 
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4.3.2 Samples 
The genomic DNA samples used in this study were part of the Singapore Genome 
Variation Project
1
, whose aim was to characterize the extent of common genetic 
polymorphisms and the haplotypes in each of the three ethnic groups in Singapore 
(Teo et al., 2009). Peripheral blood DNA was extracted from a total of 292 
individuals and genotyped using the Illumina Human 1M Beadchip and the 
Affymetrix Genome-wide Human SNP Array 6.0.  
4.3.3 Results 
We identified an average of 207, 179 and 126 ROHs per individual for Chinese, 
Malays and Indians respectively. Indians have lower numbers as well as lower total 
length of ROHs as compared to Chinese and Malays. About 83% of the ROHs are 
within the 500 kb to 1 Mb size range while 17% of them are greater than 1 Mb.  
Using the individual regions to form common regions (using the software from Study 
I), we obtain 1256 common ROH loci in the three populations. We study the 
relationship of the common ROHs with haplotype frequency, LD and positive 
selection. For each locus, we test for differences among the 3 populations in terms of 
ROH frequencies and haplotype frequencies, and 47 loci (<4%) differ significantly in 
frequencies while 899 loci (69%) differ significantly in haplotype frequencies among 
the populations. One interesting example is a 700 kb region in Chromosome 16 that 
overlaps with the Vitamin K epoxide reductase complex subunit 1 (VKORC1) gene, 
                                                          
1
 approved by the National University of Singapore – Institutional review Board (Reference Code: 07 – 
199E) 
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where genetic polymorphisms within this gene has been found to correlate with 
differences in warfarin dosage and response (Aquilante et al., 2006; Harrington et al., 
2005). In the Singapore populations, the Indians were observed to display warfarin 
resistance, thus requiring a higher dose as compared to the Chinese and Malays (Zhu 
et al., 2007). The ROH frequencies of this region are 21%, 13% and 20% for the 
Chinese, Malays and Indians respectively (no significant difference in frequencies). 
However, the haplotypes frequencies of this region among the three populations differ 
drastically (Table 4.1), especially between the Indians and the other two populations.   
 Haplotype A Haplotype B 
Chinese 0.31 0.0052 
Malay 0.28 0.045 
Indian  0.0060 0.34 
Table 4.1: Haplotype frequencies of three populations in an ROH that overlaps 
VKORC1 gene (from Teo et al., 2012). 
With regards to haplotype frequency and regional LD, we find that the frequency of 
an ROH is positively associated with the total frequency of the top three haplotypes 
as well as with regional LD. The majority of regions detected for recent positive 
selection and regions with differential LD between populations overlap with the ROH 
loci. When we consider both the location of the ROHs and the allelic form of the 
ROHs, we are able to separate the populations by principal component analysis 
(PCA), demonstrating that ROHs contain information on population structure and the 
demographic history of a population.  
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4.4 Study IV: Statistical challenges associated with detecting CNVs using next-
generation sequencing (NGS) technology.  
4.4.1 Motivation 
Whole genome re-sequencing for the identification of CNVs has gained popularity 
with the recent development of NGS platforms that allow massive parallel sequencing. 
These techniques have the potential to discover smaller CNVs that were not 
previously discovered and detect balanced rearrangements such as inversions and 
translocations. However, analysing NGS data for CNVs is a new and challenging 
field, with no standard protocols or quality control measures. Also, due to the 
complexity of the genome and the short read lengths from NGS technology, there are 
still many challenges associated with the analysis of NGS data for CNVs, no matter 
which method or algorithm is used.   
4.4.2 Results 
We describe and discuss areas of potential biases in CNV detection using NGS data, 
focusing on issues pertaining to (1) mappability, (2) GC-content bias, (3) quality-
control measures of reads, and (4) difficulties in identifying duplications. To gain 
insights to some of the issues discussed, we download real data from the 1000 
Genomes Project and analyse its depth of coverage (DOC) data. We show examples 
of how reads in repeated regions can affect CNV detection, demonstrate current GC 
correction algorithms, investigate sensitivity of DOC algorithm before and after 
quality-control of reads and discuss reasons for which duplications are harder to 
detect than deletions.  
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Chapter 5 - DISCUSSION 
5.1 What makes a good CNV detection method? 
The quality of a CNV detection method (including the technology and algorithm) can 
be broadly attributed to three aspects: (1) location (2) breakpoints (3) genotype. The 
location and breakpoints of a CNV are closely related, where the breakpoints are 
given by the start and end positions of a CNV, and the location is the entire region 
that spans from the start position to the end position. Most studies use the location 
and breakpoints to determine sensitivity and specificity of a method. However, with 
SNP/aCGH arrays, the start and end positions are technically not the true start/end 
positions of a CNV, but rather the start and end probes of the array that was used. 
Hence, breakpoint precision is highly affected by the resolution of the array. An array 
with denser probes at and near the location of the CNV will be able to detect the 
start/end of the CNV with higher precision.  
Another less-frequently used criteria for evaluating CNV detection methods is the 
ability to discern the actual copy number of the region, for example 0 copy versus 1 
copy for deletions and 3 or more copies for duplications. This is also known as 
„genotyping‟ of the CNV. Many algorithms use a clustering procedure, assuming that 
most individuals have normal „2 copies‟.  
5.2 Concordances among CNV detection methods      
From experience of several peer reviews we got during our submission of the 
manuscripts, many reviewers are often concerned about the low concordance between 
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the CNVs generated by our methods as compared to the reference list we use. 
However, this low concordance is often not a very good indicator of bad algorithm 
performance per se, but rather a more general problem in CNV detection. For 
example, in McCarroll et al. (2008)‟s study, they employed a set of very strict criteria 
on duplicate experiments in SNP arrays to define common CNV regions in eight 
HapMap samples. Despite that, (on average) 76% of the regions do not overlap with 
the list of regions found using sequencing. Even when applied to the same raw data, 
Pinto et al. (2011) found that different analytic tools typically yield CNV calls with 
<50% concordance. The low concordance can be attributed to several factors such as 
(1) lack of a true gold standard, (2) noisy data resulting in many false identifications 
and (3) imprecision of the breakpoints identified.  
Indeed, the first step of determining the sensitivity of a method is to obtain a „true 
positive‟ dataset. Hence, the first problem with CNV analysis: we do not know the 
„true positives‟! The closest bet is to use published results from studies that are well-
validated as a reference panel, and that is often only possible if you have the same 
samples as that in the reference panel. HapMap samples are commonly used in 
methodology research, usually for two main reasons: the raw data are readily 
available and there are several studies which have characterized the CNV profiles for 
these individuals and often used as the „gold standard‟ (Kidd et al., 2008; McCarroll 
et al., 2008; Conrad et al., 2010). When this is not possible, simulation is another way 
to estimate the sensitivity of the method.  
After we have chosen our „gold standard‟ dataset, the second difficulty in accessing 
sensitivity is in answering the question “Is CNV1 and CNV2 the same variant?” In 
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Figure 5.1a, when the breakpoints of the two variants match perfectly, there is no 
doubt in calling them the same variant. In Figure 5.1b, the breakpoints are different 
but the two variant have a good amount of overlap and are of roughly the same length. 
What about in Figure 5.1c where one breakpoint coincides but the length of the 
variant differs by a lot? Some studies use a relaxed criterion of calling two variants 
the same as long as there is a single base overlap, while other studies may be as 
stringent as requiring at least an 80% reciprocal overlap. A 50% reciprocal overlap 
seems to be adopted by the majority of studies in recent years. To avoid the need to 
choose this arbitral percentage, some studies define sensitivity as the proportion of 
bases that overlap. 
 
 Figure 5.1: Diagram illustrating the non-triviality of determining if two CNVs are the 
„same‟ variant.  In (a), CNV1 and CNV2 overlap completely. In this case, we are 
confident that the two CNVs are the same. In (b), the start and end positions of CNV1 
and CNV2 differs, but there is substantial overlap between the two. In (c), CNV1 is 
completely within the range of CNV2 but the two CNVs differ vastly in lengths. In 
most research papers, scientists are comfortable with using a 50% reciprocal overlap 
to determine if two CNVs are concordant.  
5.3 Problems caused by repetitive DNA 
Repetitive DNA poses challenges in CNV detection regardless whether SNP arrays or 
sequencing methods are used. For SNP arrays, the density of SNP probes in 
segmental duplicated regions is sparse due to technical difficulties in assay design and 
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implementation (Winchester et al., 2009) resulting in a bias against detecting CNVs 
in segmental duplicated regions using SNP arrays.  
For sequencing, reads that fall in repetitive DNA cause problems in alignment and 
assembly algorithms (Treangen et al., 2012). This problem is exacerbated in NGS (as 
compared to Sanger sequencing) because the sequenced reads from NGS are 
relatively short (35-150bp). Furthermore, mutations or sequencing errors in one or 
two locations may also cause reads to be mapped wrongly (Li et al., 2008). In the 
1000 Genomes trios Project, about 20% of the reference genome was considered 
inaccessible (defined as regions with many ambiguously placed reads or unexpectedly 
high or low numbers of aligned reads). The resulting low sensitivity in detecting 
CNVs in repeated/segmental-duplicated regions is a serious problem, because there is 
an observed enrichment of CNVs in segmental duplicated regions and many 
breakpoints lie in duplicated regions (Medvedev et al., 2009).  
For assembly-based methods, repeat regions create challenges because if the read 
length is shorter than the repeat region, it is not straightforward to decipher the 
original sequence since overlap between the reads or contigs will be ambiguous 
(Knudsen et al., 2010). For other methods that require mapping to a reference, there 
are different alignment strategies for dealing with multi-reads, such as (1) discarding 
the reads, (2) choosing a position at random out of all equally good match positions, 
and (3) reporting all possible positions. In Study IV, we have shown why these 
strategies are inadequate for dealing with multi-reads.  
47 
 
Recently, there are several algorithms that claim to be able to resolve specific types of 
CNVs in repeat regions. For example, He et al. (2011) developed an algorithm for 
tandem copy number variation reconstruction in repeat-rich regions, which considers 
all locations of possible mappings and uses information on read-pair and DOC. Alkan 
et al. (2009) developed a new alignment method, mrFAST. The aligner maps short 
sequence reads to a repeat-masked reference genome, meaning that all loci with 
known high-copy common repeats were first masked before alignment, and reports all 
mapping locations for multi-reads. It also keeps track of mutation in multi-reads. This 
method has been shown to be able to predict absolute copy number and multicopy 
differences. Sudmant et al. (2010) also uses a similar approach to identify and 
genotype CNVs within segmental duplications. However, these approaches seem to 
work only for deeply sequenced data (>20X), and more has to be done to extend these 
methods for lower coverage data (Chiang et al, 2009).   
Longer read lengths from third generation sequencing may partially solve the 
problems with repeats, but even with a read length of 1kb, there still remains about 
1.5% of the human genome sequence that is non-unique (Schatz et al., 2010). 
5.4 A peek into third generation sequencing (TGS) 
Third generation sequencing (TGS) or also known as single molecule sequencing 
(SMS) promises to improve sequencing rates, throughput and read lengths as 
compared to NGS. Since it does not require repeated stepwise „washing and scanning‟ 
procedures like in NGS, TGS may increase the sequencing cycle by four orders of 
magnitude (Eid et al., 2009). The first commercially available SMS instrument is the 
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HeliScope Single Molecular Sequencer by Helicos Biosciences; however, the read 
lengths are still short at ~32 bases long (Schadt et al., 2010). Since PCR amplification 
is not required in TGS, bias observed in NGS in depth of coverage due to PCR may 
be resolved. The longer read lengths of TGS will also improve challenges caused by 
the short read lengths of NGS. Time will reveal if TGS can fulfil its promises for 
advancement over NGS.  
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CHAPTER 6 - CONCLUSIONS 
 Copy number variations, ROHs and other structural variations are an 
important source of variation in the human genome, and have been associated 
with many complex diseases. 
 Due to the multi-base and multi-allelic nature of these variants, detecting them 
with high sensitivity and specificity is still a challenge. Hence, new statistical 
methods and user-friendly bioinformatics tools are needed for the analyses of 
these variants. 
 In Study I, we develop a method that allows users to detect common CNV 
regions. 
 In Study II, we develop a method that allows users to detect CNVs using 
information from multiple platforms simultaneously.  
 There is a lack of studies investigating regions of homozygosity in Asian 
populations. There is also a lack of understanding of the relationships between 
ROHs and haplotype frequency, linkage disequilibrium and positive selection. 
These are addressed in Study III.  
 Next-generation sequencing has the potential to detect CNVs beyond the 
resolution of SNP arrays and aCGH, as well as detect copy neutral SVs such 
as inversions and translocations. 
 Analytical methods and algorithms for CNV detection using NGS are not yet 
mature and there are still many challenges. In Study IV, we describe and 
discuss challenges faced in CNV detection using NGS data.   
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Chapter 7 – FUTURE DIRECTIONS AND PERSPECTIVES  
The field of genetics and genomics has progressed a long way since the first human 
genome was sequenced in 2000. By now, there are thousands of genes and loci 
discovered that are associated with simple and complex human diseases, and many of 
the discoveries were made via GWAS of SNPs. SVs, on the other hand, were much 
less considered in association studies, particularly attributed to technical difficulties in 
characterizing SVs with high resolution. Recent development of high-throughput 
sequencing presents new opportunities for identifying SVs, especially the smaller 
CNVs that were beyond the resolution of old techniques, as well as copy-neutral 
events such as inversions and translocations. However, there are still many problems 
associated with identifying SVs using NGS technology, as discussed in Study IV. As 
the technology and analytical methods continue to improve, some of these problems 
may resolve. However, it is of my personal opinion that the following cannot be 
neglected:  
1. Collaborations among various research centres. Even as the cost for whole 
genome high-throughput sequencing continues to drop, routine sequencing of 
a large number of individuals will still remain too pricy for the majority of 
research centres. Collaborations will push the research at a faster pace, 
overcoming cost and manpower issues. Take for example the 1000 Genomes 
Project (www.1000genomes.org), which aims to sequence 2500 individuals, 
and have thus far completed the sequencing of more than 1000 individuals. 
Such an effort was the result of collaborations of more than 70 research 
groups and would definitely not have been possible by a single research centre.  
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2. Well-studied and standardized analysis pipelines and quality-control (QC) 
metrics. One of the major difficulties in comparing SVs among different 
studies is that all studies use different algorithms and QC metrics. With NGS 
technology, there are already numerous algorithms to choose from, but yet no 
consensus on the appropriate analysis pipeline.   
3. Educating a whole new discipline of „big data biology‟. As more and more 
genomics data are collected, the growing need for storage, processing and 
analysis of the data becomes more and more apparent. Already, there is a great 
demand for information technology infrastructure and bioinformatics team to 
analyse the massive amount of data, with speculations that the costs associated 
with down-handling, storing and analysis of the data could be more than the 
production of the data. Hence, we need to train new scientists to handle these 
upcoming challenges.  
4. Beyond discovery studies. Many early works on population wide SVs are 
„discovery‟ studies where SVs in a population are characterized. As our 
understanding of SVs continues to increase, we should look beyond 
„discovery‟, but aim to collect phenotype data for association studies.  
5. Integrated knowledge with RNAseq, transcriptome, proteomics etc. We still 
do not have a good understanding of the function of SVs in the context of 
human phenotypes. The integrated knowledge of SVs with transcriptome and 
proteomics will enhance our ability to interpret the genome.  
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